Publication:
The myeloprotective effect of high dose medroxyprogesterone acetate (HD-MPA) in patients with carcinoma of the uterine cervix (stage II & III) treated by radiation

Simple item page
dc.contributor.authorSupatra Sangruchien_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-07-04T07:26:46Z
dc.date.available2018-07-04T07:26:46Z
dc.date.issued1996-12-01en_US
dc.identifier.citationJournal of the Medical Association of Thailand. Vol.79, No.9 (1996)en_US
dc.identifier.issn01252208en_US
dc.identifier.other2-s2.0-18244418070en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/17661
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=18244418070&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleThe myeloprotective effect of high dose medroxyprogesterone acetate (HD-MPA) in patients with carcinoma of the uterine cervix (stage II & III) treated by radiationen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=18244418070&origin=inwarden_US

Files

Collections

Scopus 1991-2000